Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Zhiming Shao"'
Autor:
Xiuzhi Zhu, Xiaohan Ying, Yin Liu, Yunyi Wang, Li Chen, Zhiming Shao, Xi Jin, Yizhou Jiang, Zhonghua Wang
Publikováno v:
Cancer Biology & Medicine, Vol 21, Iss 9, Pp 784-798 (2024)
Objective: Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive cancer. Although our previous study classified primary TNBC into four subtypes, comprehensive longitudinal investigations are lacking. Methods: We assembled a large-sca
Externí odkaz:
https://doaj.org/article/12860b20abc14875b94fe777570f3449
Autor:
Boyue Han, Xiangchen Han, Hong Luo, Javaria Nasir, Chao Chen, Zhiming Shao, Hong Ling, Xin Hu
Publikováno v:
Cancer Innovation, Vol 3, Iss 5, Pp n/a-n/a (2024)
Abstract Background Triple‐negative breast cancer (TNBC) displays high heterogeneity. The majority of TNBC cases are characterized by high Ki‐67 expression. TNBC with low Ki‐67 expression accounts for only a small fraction of cases and has been
Externí odkaz:
https://doaj.org/article/025a98f2be93471db99060ffc4db82b5
Publikováno v:
Cancer Biology & Medicine, Vol 21, Iss 5, Pp 400-415 (2024)
Objective: Mammographic calcifications are a common feature of breast cancer, but their molecular characteristics and treatment implications in hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) breast cancer
Externí odkaz:
https://doaj.org/article/e3bc9c83ef27494cb38ea30417eb3846
Autor:
Xinxin Rao, Xuanyi Wang, Chao He, YiZhou Jiang, ZhiMing Shao, Yan Feng, Jundong Zhou, Xiaomao Guo, Xingxing Chen
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 8, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/bb2b77c648734e7e9d2ab60b1d7ca54a
Autor:
Min He, Shuang Hao, LinXiaoxi Ma, BingQiu Xiu, BenLong Yang, ZeHao Wang, JingYan Xue, YaYun Chi, Min Xiong, JiaJian Chen, XiaoYan Huang, XiYu Liu, SongYang Wu, Qin Xiao, Yan Huang, RuoHong Shui, AYong Cao, JunJie Li, GenHong Di, WenTao Yang, Xin Hu, GuangYu Liu, KeDa Yu, YiZhou Jiang, ZhongHua Wang, ZhiMing Shao, Jiong Wu
Publikováno v:
EClinicalMedicine, Vol 74, Iss , Pp 102700- (2024)
Summary: Background: Toripalimab, a novel PD-1 antibody, is approved for treatment of multiple solid tumors; however, its neoadjuvant use with chemotherapy for triple-negative breast cancer (TNBC) remains unevaluated. Additionally, induction chemothe
Externí odkaz:
https://doaj.org/article/8620611ec0bb4bdcbdb47cc79155784e
Autor:
Bin He, Rui Gao, Shasha Lv, Ailin Chen, Junxiu Huang, Luoxuan Wang, Yunxiu Feng, Jiesi Feng, Bing Liu, Jie Lei, Bing Deng, Bai Cui, Fei Peng, Min Yan, Zifeng Wang, Eric W-F Lam, Bilian Jin, Zhiming Shao, Yulong Li, Jianwei Jiao, Xi Wang, Quentin Liu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-19 (2023)
Abstract Cancer cell receives extracellular signal inputs to obtain a stem-like status, yet how tumor microenvironmental (TME) neural signals steer cancer stemness to establish the hierarchical tumor architectures remains elusive. Here, a pan-cancer
Externí odkaz:
https://doaj.org/article/c3d30b364e7949b09e96698150afc296
Publikováno v:
Cancer Biology & Medicine, Vol 19, Iss 2, Pp 187-201 (2022)
Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by its highly aggressive behavior, early recurrence, and poor outcomes, when compared with other subtypes. Due to the absence of the estrogen receptor, progesterone rece
Externí odkaz:
https://doaj.org/article/bb718576710f458bacb8092280eef331
Autor:
Chunyu Wu, Chenping Sun, Guangyu Liu, Yuenong Qin, Xiaohong Xue, Xueqing Wu, Qun Wang, Jin Liu, Zhen Ye, Qiong Li, Wenchao Qu, Yi Wang, Shuai Zhang, Zhiming Shao, Sheng Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeTo evaluate the efficacy of the Sanyin formula (SYF) plus conventional standard chemotherapy in operable triple-negative breast cancer (TNBC) patients, a randomized controlled trial was implemented at 5 hospitals and cancer centers in China be
Externí odkaz:
https://doaj.org/article/bf3e12b9953743db9206411e10483f80
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe prognosis of lymph node-negative triple-negative breast cancer (TNBC) is still worse than that of other subtypes despite adjuvant chemotherapy. Reliable prognostic biomarkers are required to identify lymph node-negative TNBC patients at
Externí odkaz:
https://doaj.org/article/42a66932abec4bfea108a72912254403
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background Accumulating studies have focused on the oncogenic roles of the newly identified lncRNAs in human cancers. The aim of this study was to examine the expression pattern of Linc00959 in BC and to evaluate its biological role and clin
Externí odkaz:
https://doaj.org/article/082663d9ceda4152b8e8c91bd8d291d2